ID: ALA5281624

Max Phase: Preclinical

Molecular Formula: C19H19ClN8O4S

Molecular Weight: 490.93

Associated Items:

Representations

Canonical SMILES:  COCCOc1cc2ncnc(Sc3nnnn3-c3ncc(Cl)cn3)c2cc1OCCOC

Standard InChI:  InChI=1S/C19H19ClN8O4S/c1-29-3-5-31-15-7-13-14(8-16(15)32-6-4-30-2)23-11-24-17(13)33-19-25-26-27-28(19)18-21-9-12(20)10-22-18/h7-11H,3-6H2,1-2H3

Standard InChI Key:  CCYLHHOMZODKCF-UHFFFAOYSA-N

Associated Targets(Human)

Lysine-specific histone demethylase 1 3916 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 490.93Molecular Weight (Monoisotopic): 490.0938AlogP: 2.25#Rotatable Bonds: 11
Polar Surface Area: 132.08Molecular Species: NEUTRALHBA: 13HBD: 0
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.52CX LogP: 2.88CX LogD: 2.88
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.23Np Likeness Score: -1.77

References

1. Song Y, Zhang H, Yang X, Shi Y, Yu B..  (2022)  Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.,  228  [PMID:34915312] [10.1016/j.ejmech.2021.114042]

Source